Skip to main content

Research Repository

Advanced Search

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Parodis, Ioannis; Girard-Guyonvarc'h, Charlotte; Arnaud, Laurent; Distler, Oliver; Domján, Andrea; Van den Ende, Cornelia H M; Fligelstone, Kim; Kocher, Agnes; Larosa, Maddalena; Lau, Martin; Mitropoulos, Alexandros; Ndosi, Mwidimi; Poole, Janet L; Redmond, Anthony; Ritschl, Valentin; Alexanderson, Helene; Sjöberg, Yvonne; Von Perner, Gunilla; Uhlig, Till; Varju, Cecilia; Vriezekolk, Johanna E; Welin, Elisabet; Westhovens, René; Stamm, Tanja A; Boström, Carina

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis Thumbnail


Authors

Ioannis Parodis

Charlotte Girard-Guyonvarc'h

Laurent Arnaud

Oliver Distler

Andrea Domján

Cornelia H M Van den Ende

Kim Fligelstone

Agnes Kocher

Maddalena Larosa

Martin Lau

Alexandros Mitropoulos

Profile Image

Dr Mwidimi Ndosi Mwidimi.Ndosi@uwe.ac.uk
Associate Professor in Nursing Rheumatology

Janet L Poole

Anthony Redmond

Valentin Ritschl

Helene Alexanderson

Yvonne Sjöberg

Gunilla Von Perner

Till Uhlig

Cecilia Varju

Johanna E Vriezekolk

Elisabet Welin

René Westhovens

Tanja A Stamm

Carina Boström



Abstract

Objective: To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). Methods: A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A-D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0-10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting. Results: Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc. Conclusions: The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician-patient communication and improved outcomes.

Citation

Parodis, I., Girard-Guyonvarc'h, C., Arnaud, L., Distler, O., Domján, A., Van den Ende, C. H. M., …Boström, C. (in press). EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Annals of the Rheumatic Diseases, https://doi.org/10.1136/ard-2023-224416

Journal Article Type Article
Acceptance Date Jun 20, 2023
Online Publication Date Jul 10, 2023
Deposit Date Jul 12, 2023
Publicly Available Date Jul 13, 2023
Journal Annals of the Rheumatic Diseases
Print ISSN 0003-4967
Electronic ISSN 1468-2060
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1136/ard-2023-224416
Public URL https://uwe-repository.worktribe.com/output/10932320
Publisher URL https://ard.bmj.com/content/early/2023/07/10/ard-2023-224416

Files


EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis (401 Kb)
PDF

Licence
http://creativecommons.org/licenses/by-nc/4.0/

Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/

Copyright Statement
This article has been accepted for publication in Annals of the Rheumatic Diseases, 2023 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/ard-2023-224416.

© Authors (or their employer(s)) 2023.

Reuse of this manuscript version (excluding any databases, tables, diagrams, photographs and other images or illustrative material
included where a another copyright owner is identified) is permitted
strictly pursuant to the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC-BY-NC 4.0) http://creativecommons.org. https://creativecommons.org/licenses/by-nc/4.0/







Related Outputs



You might also like



Downloadable Citations